| 90.37 2.58 (2.94%) | 11-11 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 106.49 | 1-year : | 124.38 |
| Resists | First : | 91.18 | Second : | 106.49 |
| Pivot price | 88.2 |
|||
| Supports | First : | 85.24 | Second : | 81.56 |
| MAs | MA(5) : | 87.37 |
MA(20) : | 88.07 |
| MA(100) : | 88.47 |
MA(250) : | 90  |
|
| MACD | MACD : | -0.3 |
Signal : | -0.5 |
| %K %D | K(14,3) : | 70.3 |
D(3) : | 49.7 |
| RSI | RSI(14): 58.4 |
|||
| 52-week | High : | 109.58 | Low : | 71.41 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ LMAT ] has closed below upper band by 13.8%. Bollinger Bands are 28% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 91.05 - 91.41 | 91.41 - 91.79 |
| Low: | 87.32 - 87.7 | 87.7 - 88.08 |
| Close: | 89.74 - 90.41 | 90.41 - 91.09 |
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
Tue, 11 Nov 2025
3 Reasons Why Growth Investors Shouldn't Overlook LeMaitre (LMAT) - sharewise.com
Tue, 11 Nov 2025
3 Reasons Why Growth Investors Shouldn't Overlook LeMaitre (LMAT) - Yahoo Finance
Sun, 09 Nov 2025
LeMaitre Vascular (LMAT): Assessing Valuation After Strong Q3 Results and Upbeat Full-Year Guidance - simplywall.st
Sun, 09 Nov 2025
LeMaitre targets 40% Q4 operating income growth and 29% margin as Artegraft expansion accelerates - MSN
Sun, 09 Nov 2025
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q3 2025 Earnings Call Transcript - Insider Monkey
Sat, 08 Nov 2025
Decoding LeMaitre Vascular Inc (LMAT): A Strategic SWOT Insight - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 23 (M) |
| Shares Float | 21 (M) |
| Held by Insiders | 7.8 (%) |
| Held by Institutions | 94.8 (%) |
| Shares Short | 1,220 (K) |
| Shares Short P.Month | 1,270 (K) |
| EPS | 2.04 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 16.02 |
| Profit Margin | 20 % |
| Operating Margin | 25.1 % |
| Return on Assets (ttm) | 7.2 % |
| Return on Equity (ttm) | 13.8 % |
| Qtrly Rev. Growth | 15 % |
| Gross Profit (p.s.) | 7.16 |
| Sales Per Share | 10.36 |
| EBITDA (p.s.) | 2.86 |
| Qtrly Earnings Growth | 15.3 % |
| Operating Cash Flow | 59 (M) |
| Levered Free Cash Flow | 38 (M) |
| PE Ratio | 44.08 |
| PEG Ratio | 0 |
| Price to Book value | 5.64 |
| Price to Sales | 8.71 |
| Price to Cash Flow | 34.81 |
| Dividend | 0.2 |
| Forward Dividend | 0 |
| Dividend Yield | 0.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|